Paragon for Patients

Paragon Biosciences invests in and launches innovative companies which develop critically-needed medicines. Paragon’s portfolio companies are managed by healthcare industry leaders and biotech entrepreneurs committed to delivering better outcomes.

Paragon’s leadership and management team have a strong track record at earning FDA approvals. Paragon puts its expertise to use to finance and launch innovative biotech companies and accelerate their scientific breakthroughs.


How We Work

Groundbreaking discovery requires scientific rigor, technology, and an unyielding commitment to the patients we serve.

During early incubation, we provide our portfolio companies with dedicated experts and turnkey administrative systems. In addition, we help portfolio companies to recruit entrepreneurial leaders and clinical experts to provide the strategy, guidance, and support they need to ensure that important medicines reach patients.

Portfolio companies conduct all phases of clinical trials and development and collaborate with top medical professionals. We are relentless in applying speed and efficiency to bring novel medicines to patients in need.


Our Partners

We partner with those who share our patient-first commitment to developing new medicines.

Artboard 6.png
Vivo.jpg
Artboard 5.png
HBM-HealthcareInvestments.jpg
Novo-Holdings.jpg
Ven-Bio.jpg